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eMethods. VDAART Study  
Pregnant women (who reported or whose partner reported allergies/asthma) were randomized 
(n=880) during the first trimester of pregnancy (10-18 weeks) to one of two treatment arms of a 
clinical trial: 4000 IU vitamin D + prenatal vitamins or 400 IU vitamin D + prenatal vitamins. 
Seventy infants were excluded, due to fetal or neonatal deaths (N=29), loss to follow-up during 
the prenatal period (N=27) or loss to follow-up after delivery (N=3).  Of the 810 infants 
remaining, 333 infants donated stool samples.   
Stool sample Collection and Sequencing of Bacterial 16S rRNA gene  
Mothers were asked to collect ½ teaspoon of their infant’s stool from a dirty diaper using a 
tongue depressor and to store the sample in their home freezer.  Frozen stool samples were then 
brought to the clinical center by the infant’s mother within 1-2 days or picked up at participants’ 
homes within 24 hours of collection and stored at -80oC.   Stool samples were not collected if the 
infant had taken antibiotics within the past 7 days. A total of 333 infants had stool samples (age 
3-6 months) collected.    DNA extractions were performed on stool samples, and the bacterial 
rRNA 16S gene (V3 to V5 hyper-variable regions) was amplified.  Pyrosequencing data (Roche 
454 Titanium) were produced by the Genome Center (TGI) at Washington University in St. 
Louis, MO.  
Bioinformatics Pipeline for Processing of Bacterial 16S Sequences 
Quality filtering, trimming, and chimera checking were performed.   The quality filtering 
protocol used allows one mismatch in the primer and zero mismatches in the barcode.  Chimera 
slayer software was used to remove chimeric reads.  All samples that passed quality control 
screening were classified from phylum to genus level at a confidence threshold of 0.5 using the 
Ribosomal Database Project Naive Bayesian Classifier version 2.2, training set 6. The reads 
whose taxonomic assignments were lower than a 0.5 confidence threshold were assigned to the 
unclassified group. All samples were scaled to 1000 reads before analysis. 
Covariates (Additional information about Race classification)  
 Infant’s racial/ethnic group was derived from initial enrollment data on race/ethnicity of each 
biological parent.  The ‘African American’ race/ethnicity category included infants of African 
American ancestry only, as well as those with mixed African and Hispanic ancestry.  Infants of 
Native American or Asian descent were included in the ‘Other’ race category. 





MaAsLin analytic software performs boosted, additive general linear models to detect 
associations between one group of data (metadata/predictors, including ASQ-3 binary outcomes 
for typical development vs. potential delayed development) and another group (microbial 
abundance of specific taxa).  In this multivariate approach, all measured taxa are considered as 
outcomes simultaneously. 





eTable 1. ASQ-3 Cut-points for Score Categories of “Typical,” “Need for Monitoring,” and “Need for Further Assessment” 
ASQ Domain Typical Need for Monitoring Need for Further Assessment 
Communication Score > 40 30.99 - 40 <30.99 
Gross Motor Score >46 36.99 – 46 <36.99 
Fine Motor Score >32.5 18.07 – 32.5 <18.07 
Problem Solving Score >41 30.29 – 41 <30.29 
Personal/Social Score >44 35.3 - 44 <35.33 
*ASQ-3=Ages and Stages Questionnaire 3rd Edition 























*VDAART=Vitamin D Antenatal Asthma Reduction Trial **U. denotes “Unclassified” at lower taxonomic levels
 Bacterial Co-abundance Factor Loadings 
 Factor 1 Factor 2 Factor 3 Factor 4 
Bacteroides -0.31 -0.28 0.70 -0.22 
Escherichia Shigella -0.23 -0.28 -0.44 -0.07 
Bifidobacterium -0.28 -0.17 -0.47 0.00 
Veillonella -0.08 0.08 0.15 0.66 
Blautia XIV 0.23 0.02 0.06 -0.08 
Enterococcus -0.02 0.05 -0.29 -0.11 
Klebsiella -0.05 0.46 -0.01 0.02 
Streptococcus -0.09 0.00 -0.20 0.18 
Lachnospiraceae Dorea 0.59 -0.08 -0.14 -0.23 
Lachnospir. Coprococcus 0.41 0.00 0.06 0.24 
Lachnospiraceae U.** 0.82 -0.02 -0.06 -0.09 
Parabacteroides -0.05 -0.17 0.28 -0.23 
Collinsella -0.03 0.05 0.08 -0.23 
Lactobacillus -0.20 -0.05 -0.12 0.15 
Clostridium 0.03 0.12 -0.07 0.36 
Coprobacillus 0.16 -0.02 -0.14 0.02 
Sporacetigenium 0.14 0.06 -0.13 0.08 
Enterobacteriaceae U.** -0.04 0.86 -0.06 -0.05 
Enterobacter -0.07 0.76 0.00 -0.17 
Holdemania 0.29 -0.01 -0.03 -0.10 
Megasphaera -0.09 0.06 0.06 -0.10 
Eubacterium 0.21 -0.03 0.08 0.06 
Akkermansia 0.06 0.07 0.00 -0.12 
Clostridiales U.** 0.65 -0.02 0.07 0.01 
Lactococcus 0.04 0.05 -0.03 -0.15 




eTable 3. MaAsLin Analysis Results:  Associations of Gut Microbiome Taxa (Those Present in at Least 10 Subjects) in Infants 
(Ages 3-6 Months) with Typical Communication Development on the ASQ-3 at Age 3 Years, N=307 
Feature Coefficient N not 0** p value q Value  
(FDR adjusted p value) Order Family Genus 
Flavobacteriales Weeksellaceae Chryseobacterium 0.002759 20 0.013 0.566475 
Clostridiales Veillonellaceae Acidaminococcus -0.01418 14 0.015634 0.566475 
Enterobacteriales Enterobacteriaceae Salmonella -0.00271 22 0.015689 0.566475 
Lactobacillales Enterococcaceae Unclassified -0.0118 135 0.019703 0.566475 
Enterobacteriales Enterobacteriaceae Erwinia -0.00659 123 0.036579 0.584345 
Lactobacillales Unclassified  -0.00695 126 0.032388 0.584345 
Clostridiales Lachnospiraceae Ruminococcus -0.06541 271 0.04065 0.584345 
Clostridiales Christensenellaceae Christensenella -0.0026 10 0.036947 0.584345 
*Nominally significant features (P < 0.05) are reported.  Analysis adjusted for gestational age, race, gender, breast feeding in 1st 6 months of 
life, c-section, age at ASQ, maternal education, maternal marital status, maternal age, low income (<$30,000), antibiotics in the first days of 
life, treatment group and clinical site **Number of participants with detectable feature




eTable 4. MaAsLin Analysis Results: Association of Gut Microbiome Taxa (Those Present in at Least 10 Subjects) in Infants (Ages 
3-6 Months) with Typical Personal/Social Development on the ASQ-3 at Age 3 Years, N=307 
 
* Nominally significant features (P < 0.05) are reported.  Analysis adjusted for gestational age, race, gender, breast feeding in 1st 6 months of 
life, c-section, age at ASQ, maternal education, maternal marital status, maternal age, low income (<$30,000), antibiotics in the first days of 
life, treatment group and clinical site **Number of participants with detectable feature 
Feature Coefficient N not 0** p value q Value  
(FDR adjusted p value) Order Family Genus 
Clostridiales Lachnospiraceae Oribacterium -0.00235 16 0.003331 0.383099 
Clostridiales Ruminococcaceae Oscillospira -0.03631 218 0.007523 0.432552 
Lactobacillales Enterococcaceae Unclassified -0.01199 135 0.021813 0.627134 
Lactobacillales Leuconostocacea Weissella -0.0031 23 0.020977 0.627134 
Clostridiales Lachnospiraceae Ruminococcus_ -0.07184 271 0.029383 0.675807 
Enterobacteriales Enterobacteriaceae Salmonella -0.00235 22 0.042865 0.821583 





eTable 5. MaAsLin Analysis Results:  Association of Gut Microbiome Taxa (Those Present in at Least 10 Subjects) in Infant (Ages 
3-6 Months) with Typical Fine Motor Development on the ASQ-3 at Age 3 Years, N=307 
Feature Coefficient N not 0** p value q Value  
(FDR adjusted p value) Order Family Genus 
Enterobacteriales Enterobacteriaceae Klebsiella -0.03339 239 0.000312 0.035843 
Enterobacteriales Enterobacteriaceae Salmonella -0.00268 22 0.001024 0.058892 
Clostridiales Veillonellaceae Megasphaera -0.00418 147 0.018578 0.517589 
Coriobacteriales Coriobacteriaceae Atopobium 0.003611 100 0.020417 0.517589 
Actinomycetales Actinomycetaceae Actinomyces 0.006387 220 0.033323 0.517589 
Clostridales Veillonellaceae Phascolarctobacterium -0.01288 32 0.035419 0.517589 
Enterobacteriales Enterobacteriaceae Erwinia -0.00472 123 0.040415 0.517589 
Lactobacillales Lactobacillaceae Lactobacillus 0.002866 147 0.040478 0.517589 
Lactobacillales Streptococcaceae Streptococcus 0.031244 307 0.040507 0.517589 
*Nominally significant features (P < 0.05) are reported.  Analysis adjusted for gestational age, race, gender, breast feeding in 1st 6 months of 
life, c-section, age at ASQ, maternal education, maternal marital status, maternal age, low income (<$30,000), antibiotics in the first days of 
life, treatment group and clinical site **Number of participants with detectable feature 
 
 
